Instituto Rosenbusch S.A.
Instituto Rosenbusch S.A. manufactures and sells veterinary products in Argentina. The company offers biological products, including products for reproductive-respiratory complex, IBR, BVD, brucelosis, carbuncle, and other diseases; clostridial vaccines; vaccines for cattle, sheep, goats, horses, and dogs; and products for the prevention of pneumonia and calve diarrhea, and cattle infectious kera… Read more
Instituto Rosenbusch S.A. (ROSE) - Total Assets
Latest total assets as of September 2025: AR$8.09 Billion ARS
Based on the latest financial reports, Instituto Rosenbusch S.A. (ROSE) holds total assets worth AR$8.09 Billion ARS as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Instituto Rosenbusch S.A. - Total Assets Trend (2000–2024)
This chart illustrates how Instituto Rosenbusch S.A.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Instituto Rosenbusch S.A. - Asset Composition Analysis
Current Asset Composition (December 2024)
Instituto Rosenbusch S.A.'s total assets of AR$8.09 Billion consist of 78.2% current assets and 21.8% non-current assets.
| Asset Category | Amount (ARS) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AR$0.00 | 11.6% |
| Accounts Receivable | AR$1.50 Billion | 19.9% |
| Inventory | AR$3.07 Billion | 40.7% |
| Property, Plant & Equipment | AR$0.00 | 0.0% |
| Intangible Assets | AR$0.00 | 0.0% |
| Goodwill | AR$0.00 | 0.0% |
Asset Composition Trend (2000–2024)
This chart illustrates how Instituto Rosenbusch S.A.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Instituto Rosenbusch S.A.'s current assets represent 78.2% of total assets in 2024, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 11.6% of total assets in 2024, up from 1.4% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 2.0% in 2000.
- Asset Diversification: The largest asset category is inventory at 40.7% of total assets.
Instituto Rosenbusch S.A. Competitors by Total Assets
Key competitors of Instituto Rosenbusch S.A. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp Preferred
KO:000105
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
|
Yuyu Pharma
KO:000220
|
Korea | ₩202.42 Billion |
|
Ildong Holdings Co Ltd
KO:000230
|
Korea | ₩813.62 Billion |
Instituto Rosenbusch S.A. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Instituto Rosenbusch S.A. generates 1.10x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Instituto Rosenbusch S.A. is currently not profitable relative to its asset base.
Instituto Rosenbusch S.A. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.06 | 2.43 | 1.07 |
| Quick Ratio | 0.57 | 1.39 | 0.46 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | AR$361.84 Million | AR$ 3.42 Billion | AR$ 30.53 Million |
Instituto Rosenbusch S.A. - Advanced Valuation Insights
This section examines the relationship between Instituto Rosenbusch S.A.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 23.44 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -31.3% |
| Total Assets | AR$7.54 Billion |
| Market Capitalization | $1.57 Million USD |
Valuation Analysis
Below Book Valuation: The market values Instituto Rosenbusch S.A.'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Instituto Rosenbusch S.A.'s assets decreased by 31.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Instituto Rosenbusch S.A. (2000–2024)
The table below shows the annual total assets of Instituto Rosenbusch S.A. from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | AR$7.54 Billion | -31.32% |
| 2023-12-31 | AR$10.98 Billion | +714.64% |
| 2022-12-31 | AR$1.35 Billion | +80.38% |
| 2021-12-31 | AR$747.29 Million | +10.60% |
| 2020-12-31 | AR$675.64 Million | +35.96% |
| 2019-12-31 | AR$496.94 Million | +35.50% |
| 2018-12-31 | AR$366.76 Million | +71.76% |
| 2017-12-31 | AR$213.52 Million | +7.92% |
| 2016-12-31 | AR$197.86 Million | +19.07% |
| 2015-12-31 | AR$166.17 Million | +18.06% |
| 2014-12-31 | AR$140.75 Million | +11.81% |
| 2013-12-31 | AR$125.89 Million | +9.57% |
| 2012-12-31 | AR$114.90 Million | +32.18% |
| 2011-12-31 | AR$86.92 Million | +18.38% |
| 2010-12-31 | AR$73.42 Million | +13.87% |
| 2009-12-31 | AR$64.48 Million | +12.26% |
| 2008-12-31 | AR$57.44 Million | +6.71% |
| 2007-12-31 | AR$53.83 Million | +10.94% |
| 2006-12-31 | AR$48.52 Million | +6.48% |
| 2005-12-31 | AR$45.57 Million | +16.50% |
| 2004-12-31 | AR$39.12 Million | +9.89% |
| 2003-12-31 | AR$35.60 Million | +20.45% |
| 2002-12-31 | AR$29.55 Million | +92.70% |
| 2001-12-31 | AR$15.34 Million | +4.25% |
| 2000-12-31 | AR$14.71 Million | -- |